How do you pay?

How to pay the least

Ask for the cash price

Adzynma

Adzynma is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Adzynma’s cash price, and one or two other pharmacies too.
  2. Adzynma’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameAdzynma
Authorized genericapadamtase alfa
Regular genericapadamtase alfa
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Adzynma?
The original
–
–

Brand nameThe maker’s card

Takeda Patient Support Co-Pay Assistance Program

Savings card from Takeda

No insuranceNeeds insuranceNo cash price listed.
Insurance · up to $20,000 off a year

The card takes up to $20,000 a year off your co-pay.

Sign up on takedapatientsupport.com 

In the maker’s words

“The maximum co-pay assistance available annually is $20,000…”

From the maker’s offer on takedapatientsupport.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Adzynma itself, from the same company, sold without the brand name, and usually for less. For now Adzynma is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Adzynma is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ADZYNMA (ADAMTS13, recombinant-krhn) is a human recombinant “A disintegrin and metalloproteinase with thrombospondin motifs 13” (rADAMTS13) indicated for prophylactic or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP).

Source: the FDA label for Adzynma (TAKEDA PHARMACEUTICALS AMERICA, INC.), September 25, 2026. Full label on DailyMed 

Good to know